September 2015 SPADA Meeting

SEB Working Group Members

Sandra Tallent, FDA (Chair) Jessica Appler HHS BARDA , Patrice Arbault, BioAdvantage Consulting Jeff Ballin, ECBC Linda Beck, Naval Surface Warfare Center Don Bushner, JRO-CBRND Ryan Cahall, Censeo Insight Matthew Davenport, DHS Martha Hale, USAMRIID Kia Hopkins, ECBC Malcolm Johns, DHS Liz Kerrigan, ATCC

Karen Kesterson, PFPA Katalin Kiss ATCC , Markus Lacorn, R-Biopharm Metthew Lesho, Luminex Stephen Morse, CDC Sean O’Brien, DoD DUSA T-E Kate Ong, JPEO-CBD Tom Phillips, MD Department of Agriculture Roberto Rebeil, ECBC Reinhardt Witzenberger, R- Biopharm Emily Yost, ATEC

SEB Working Group Work to Date

• 2 In Person Meetings

• 3 teleconferences (March 2015 – May 2015)

• 1 SMPR Drafted 

• Public comment period (June 30, 2015 – July  31 2015) ,  • SMPRs made ready for SPADA review and  approval